Sunopta Stock Current Valuation
SOY Stock | CAD 11.03 0.20 1.78% |
Valuation analysis of SunOpta helps investors to measure SunOpta's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 11th of December 2024, Enterprise Value Over EBITDA is likely to drop to 23.03. In addition to that, Enterprise Value Multiple is likely to drop to 23.03. Fundamental drivers impacting SunOpta's valuation include:
Price Book 5.6935 | Enterprise Value 1.9 B | Enterprise Value Ebitda 25.5383 | Price Sales 1.845 | Forward PE 51.8135 |
Overvalued
Today
Please note that SunOpta's price fluctuation is somewhat reliable at this time. Calculation of the real value of SunOpta is based on 3 months time horizon. Increasing SunOpta's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since SunOpta is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SunOpta Stock. However, SunOpta's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 11.03 | Real 10.34 | Hype 11.07 | Naive 11.23 |
The intrinsic value of SunOpta's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence SunOpta's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of SunOpta helps investors to forecast how SunOpta stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SunOpta more accurately as focusing exclusively on SunOpta's fundamentals will not take into account other important factors: SunOpta Company Current Valuation Analysis
SunOpta's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current SunOpta Current Valuation | 1.87 B |
Most of SunOpta's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SunOpta is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
SunOpta Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for SunOpta is extremely important. It helps to project a fair market value of SunOpta Stock properly, considering its historical fundamentals such as Current Valuation. Since SunOpta's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of SunOpta's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of SunOpta's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, SunOpta has a Current Valuation of 1.87 B. This is 90.35% lower than that of the Food Products sector and 81.13% lower than that of the Consumer Staples industry. The current valuation for all Canada stocks is 88.74% higher than that of the company.
SunOpta Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SunOpta's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SunOpta could also be used in its relative valuation, which is a method of valuing SunOpta by comparing valuation metrics of similar companies.SunOpta is currently under evaluation in current valuation category among its peers.
SunOpta Fundamentals
Return On Equity | -0.04 | ||||
Return On Asset | 0.0306 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 1.87 B | ||||
Shares Outstanding | 116.92 M | ||||
Shares Owned By Insiders | 3.90 % | ||||
Shares Owned By Institutions | 89.20 % | ||||
Number Of Shares Shorted | 1.07 M | ||||
Price To Earning | 14.88 X | ||||
Price To Book | 5.69 X | ||||
Price To Sales | 1.84 X | ||||
Revenue | 630.3 M | ||||
Gross Profit | 128.55 M | ||||
EBITDA | 36.82 M | ||||
Net Income | (175.02 M) | ||||
Cash And Equivalents | 679 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 379.14 M | ||||
Debt To Equity | 0.52 % | ||||
Current Ratio | 2.16 X | ||||
Book Value Per Share | 1.38 X | ||||
Cash Flow From Operations | 14.84 M | ||||
Short Ratio | 12.60 X | ||||
Earnings Per Share | (0.10) X | ||||
Price To Earnings To Growth | 30.90 X | ||||
Target Price | 14.66 | ||||
Number Of Employees | 1.17 K | ||||
Beta | 1.82 | ||||
Market Capitalization | 1.31 B | ||||
Total Asset | 669.42 M | ||||
Retained Earnings | (332.69 M) | ||||
Working Capital | 29.84 M | ||||
Net Asset | 669.42 M |
About SunOpta Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SunOpta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SunOpta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SunOpta based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether SunOpta is a strong investment it is important to analyze SunOpta's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact SunOpta's future performance. For an informed investment choice regarding SunOpta Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SunOpta. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in SunOpta Stock, please use our How to Invest in SunOpta guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.